Is this program recognized by ACLAM? | Yes |
Does this program participate in the Veterinary Internship & Residency Matching Program (VIRMP)? | Yes
|
Number of concurrent residents | 3
|
How many residents/trainees have completed this program? | 31
|
Of these, how many have subsequently become ACLAM Diplomates? | 29
|
In what year did the program accept its first trainee? | 1987 |
How many years are required to complete this program (residency only)? | 3 |
Is formal coursework offered? | Yes
|
Is a degree program associated with this residency? | No |
If yes, what degree(s)? | |
Which departments most commonly grant degree(s)? | |
Give an overview of this program, describing its particular strengths and any unique aspects that are not addressed in any of the other sections | The greatest strengths of the residency program are a single large centralized facility, the opportunity to work with a variety of small and large animal species, the wide range of research projects occurring at any one time, collaboration with a local pharmaceutical corporation, and the outstanding ACLAM examination pass rate. The training program is supported by AbbVie and includes a nine-month pharmaceutical component. The first two years are spent in six month clinical rotations, including rodents, nonhuman primates, large animal/experimental surgery, and management. The management rotation may overlap with the research rotation, which give the fellow approximately 6 months to complete a hypothesis-driven research with a clinical or management focus. The last nine months are spent working at AbbVie in a pharmaceutical setting. The research portion is designed to meet the publication requirements for ACLAM board qualification. |
Describe any unique research interests of your faculty | Due to the size of the program, almost every conceivable type of research, testing, and teaching has been or may be in place on a given date. Areas of research emphasis at UIC include: cardiovascular disease, carcinogenesis, chemotherapeutics/prevention, infectious disease, lung injury, metabolic disease, neurodegenerative disease, ophthalmic disorders, safety and efficacy testing, teaching and training, transplantation, immunotolerance, and wound healing. |
Give a few literature citations of publications completed by trainees during their tenure in this program | Greenstein AW, Boyle-Vavra B, Maddox CW, Tang X, Halliday LC, Fortman JD. Characterization of methicillin-resistant Staphylococcus aureus (MRSA) carriage in a colony of rhesus (Macaca mulatta) and cynomolgus Macaques (Macaca fascicularis). Submitted to Comparative Medicine Aug 2018. Eichner M, Purcell JE, Fortman JD. Effects of Intracage Ammonia on Markers of Pulmonary Endothelial Integrity in Mice Housed in Static Microisolation Cages. J Am Assoc Lab Anim Sci. 2018 Jan 1;57(1):18-23. Clark SE, Purcell JE, Bi X, Fortman JD. Cross-Foster Rederivation Compared with Antibiotic Administration in the Drinking Water to Eradicate Bordetella pseudohinzii. J Am Assoc Lab Anim Sci. 2017 Jan; 56(1): 47–51. Clark SE, Purcell SE, Sammani S, Steffen EK, Crim MJ, Livingston RS, Becsh-Williford C, Fortman JD. Bordetella pseudohinzii as a confounding organism in murine models of pulmonary disease. Comp Med 2016 Oct. 66(5): 1-6.
Thiede AJ, Garcia KD, Stolarik DF, Ma J, Jenkins GJ, Nunamaker EA. Pharmacokinetics of Sustained-Release and Transdermal Buprenorphine in Göttingen Minipigs (Sus scrofa domestica). J Am Assoc Lab Anim Sci. 2014 Nov; 53(6): 692–699.
|
Where will vacancies be advertised? | VIRMP website |
What month does the program begin? | July |